Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines

NCT02797028 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DIETARY_SUPPLEMENT: Anthocyanidins capsule
DIETARY_SUPPLEMENT: Placebo capsule
DRUG: Allopurinol

Sponsor

Guangzhou General Hospital of Guangzhou Military Command

Collaborators

[object Object]